029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD721膀胱癌及边缘组织组合芯片,附TNM和临床分期,24例/72点
点 数72例 数24
行 数8列 数9
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD721
 
膀胱癌及边缘组织组合微阵列芯片,包含18例尿路上皮癌,6例边缘膀胱组织,一例三点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
Inflammation (*)
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
TISSUE  ARRAYS UBD721
1
2
3
4
5
6
7
8
9
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1159FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A2259FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A3359FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A4458MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
A5558MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
A6658MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
A7772MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
A8872MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
A9972MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
B11070MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant4*3*2N
B21170MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant4*3*2N
B31270MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant4*3*2N
B41369MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*1.5N
B51469MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*1.5N
B61569MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*1.5N
B71654MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant1*1*0.5N
B81754MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant1*1*0.5N
B91854MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant1*1*0.5N
C11976FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
C22076FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
C32176FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
C42266MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
C52366MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
C62466MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
C72554MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*2*0.6N
C82654MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*2*0.6N
C92754MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*2*0.6N
D12846MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*1.5*1N
D22946MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*1.5*1N
D33046MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*1.5*1N
D43167FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant5*5*1.5N
D53267FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant5*5*1.5N
D63367FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant5*5*1.5N
D73482MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
D83582MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
D93682MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
E13750FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*4*3N
E23850FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*4*3N
E33950FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*4*3N
E44060MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
E54160MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
E64260MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
E74368MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
E84468MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
E94568MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F14661MBladderHigh grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant*N
F24761MBladderHigh grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant*N
F34861MBladderHigh grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant*N
F44974FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
F55074FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
F65174FBladderHigh grade urothelial carcinoma (sparse)*T2bN0M0IIMalignant*N
F75248MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
F85348MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
F95448MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
G15567MBladderChronic inflammation with hyperplasia and squamous metaplasia***Inflammation*N
G25667MBladderChronic inflammation***Inflammation*N
G35767MBladderChronic inflammation with hyperplasia and squamous metaplasia***Inflammation*N
G45846FBladderChronic inflammation***Inflammation*N
G55946FBladderChronic inflammation***Inflammation*N
G66046FBladderChronic inflammation***Inflammation*N
G76178FBladderChronic inflammation***Inflammation*N
G86278FBladderChronic inflammation***Inflammation*N
G96378FBladderChronic inflammation***Inflammation*N
H16451MBladderChronic inflammation with hyperplasia and squamous metaplasia***Inflammation*N
H26551MBladderChronic inflammation with hyperplasia and squamous metaplasia***Inflammation*N
H36651MBladderChronic inflammation***Inflammation*N
H46773MBladderChronic inflammation***Inflammation*N
H56873MBladderChronic inflammation***Inflammation*N
H66973MBladderChronic inflammation***Inflammation*N
H77049FBladderChronic inflammation with hyperplasia and squamous metaplasia***Inflammation*N
H87149FBladderChronic inflammation with hyperplasia and squamous metaplasia***Inflammation*N
H97249FBladderChronic inflammation with hyperplasia and squamous metaplasia***Inflammation*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情